Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05%
Product Images NDC 72934-1011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod 5% / Levocetirizine Dihydrochloride 1% / Tretinoin 0.05% (NDC 72934-1011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D (1011 2 End)

FDA Label Image

';' (1011 2 Front)

';' (1011 2 Front)
This is a list of topical medications including Clindamycin Phosphate, Nacinamide, and Eretinoin which have different concentrations stated in percentages. It appears to be a prescription medication for treating certain skin conditions, such as acne.*
FDA Label Image

F (1011 2 Middle)

F (1011 2 Middle)
This is a description of a product that contains active ingredients including Butylated Hydroxytoluene NF (BHT), Glycerin USP, Sodium Metabisulfite NF, and Suspendisse Gel. The product lot number is OLAS20ABCTUEF, and its manufacture date is 01/01/1970.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.